biguanides has been researched along with Hyperlipemia in 24 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The biguanides were a therapeutic enrichment particularly in the treatment of adipose elderly diabetics with obligatory diet." | 1.26 | [Indications and results of an additional differentiated pharmacotherapy of obesity]. ( Kucher, E, 1978) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 18 (75.00) | 18.7374 |
| 1990's | 2 (8.33) | 18.2507 |
| 2000's | 4 (16.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kotake, H | 1 |
| Cavallero, E | 1 |
| Dachet, C | 1 |
| Assadolahi, F | 1 |
| Martin, C | 1 |
| Navarro, N | 1 |
| Ansquer, JC | 1 |
| Corda, C | 1 |
| Foucher, C | 1 |
| Juhan-Vague, I | 1 |
| Jacotot, B | 1 |
| Kume, A | 1 |
| Miyazaki, T | 1 |
| Daida, H | 1 |
| Shoukry, M | 1 |
| Jayyab, AK | 1 |
| Kasuga, M | 1 |
| Hunabiki, A | 1 |
| Morita, S | 1 |
| Ageeva, VV | 1 |
| Krasil'nikova, EI | 2 |
| Zubina, IM | 1 |
| Shliakhto, EV | 1 |
| Weisweiler, P | 2 |
| Schwandt, P | 2 |
| Koschinsky, T | 2 |
| Gries, FA | 2 |
| Hansen, W | 1 |
| Nijssen, J | 1 |
| Beckmann, R | 1 |
| Klose, G | 1 |
| Mordasini, R | 1 |
| Middelhoff, G | 1 |
| Augustin, J | 1 |
| Greten, H | 1 |
| Sangiorgi, M | 1 |
| Martinelli, M | 1 |
| Kucher, E | 1 |
| Estève, B | 1 |
| Marquié, G | 2 |
| Agid, R | 2 |
| Möricke, R | 1 |
| Marek, H | 1 |
| Winiecki, P | 1 |
| Mochow, P | 1 |
| Bindseil, S | 1 |
| Reichert, E | 1 |
| Beckmann, VR | 1 |
| Blagosklonnaia, IaV | 1 |
| Almazov, VA | 1 |
| Panzram, G | 1 |
| Delacrétaz, J | 1 |
| Muntoni, S | 1 |
| Vogelberg, KH | 1 |
| Förster, O | 1 |
| Rudas, B | 2 |
| Irsigler, K | 1 |
| Flegel, U | 1 |
| Miettinen, TA | 1 |
| Taskinen, MR | 1 |
| Pelkonen, R | 1 |
| Nikkilä, EA | 1 |
| Brand, J | 1 |
| Novak, M | 1 |
5 reviews available for biguanides and Hyperlipemia
| Article | Year |
|---|---|
[Syndrome X].
Topics: Animals; Bezafibrate; Biguanides; Fatty Acids, Nonesterified; Humans; Hyperglycemia; Hyperinsulinism | 2002 |
[Treatment for coronary artery disease patients with impaired glucose tolerance].
Topics: Acarbose; Biguanides; Coronary Artery Bypass; Coronary Artery Disease; Glucose Intolerance; Glycosid | 2005 |
[Etiology and therapy of insulin resistance].
Topics: Animals; Arteriosclerosis; Biguanides; Diabetes Mellitus, Type 2; Humans; Hyperlipidemias; Hypertens | 1999 |
[Skin and diabetes].
Topics: Biguanides; Diabetes Mellitus; Diabetic Angiopathies; Diabetic Neuropathies; Foot Diseases; Hemochro | 1973 |
Inhibition of fatty acid oxidation by biguanides: implications for metabolic physiopathology.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adipose Tissue; Animals; Biguanides; Biological Trans | 1974 |
5 trials available for biguanides and Hyperlipemia
| Article | Year |
|---|---|
Micronized fenofibrate normalizes the enhanced lipidemic response to a fat load in patients with type 2 diabetes and optimal glucose control.
Topics: Adult; Apolipoproteins B; Biguanides; Cholesterol, VLDL; Diabetes Mellitus, Type 2; Dietary Fats; Do | 2003 |
[Fliformine effects on blood lipid spectrum and lipid peroxidation in obese patients].
Topics: Biguanides; Female; Humans; Hyperlipidemias; Hypolipidemic Agents; Lipid Metabolism; Lipid Peroxidat | 2000 |
[Treatment of primary hyperlipoproteinemias type IV with different biguanides (author's transl)].
Topics: Biguanides; Buformin; Cholesterol; Female; Humans; Hyperlipidemias; Lipoproteins, VLDL; Male; Metfor | 1976 |
[Treatment of primary hyperlipoproteinemias of type IIB and IV with butylbiguanide and clofibrate (author's transl)].
Topics: Adult; Aged; Biguanides; Blood Glucose; Body Weight; Buformin; Cholesterol; Clofibrate; Drug Therapy | 1977 |
Glucose tolerance and plasma insulin in man during acute and chronic administration of nicotinic acid.
Topics: Biguanides; Blood Glucose; Carbohydrate Metabolism; Diet; Gluconeogenesis; Glucose Tolerance Test; G | 1969 |
14 other studies available for biguanides and Hyperlipemia
| Article | Year |
|---|---|
Plasma HDL in non-insulin-dependent diabetes and the effect of various types of treatment.
Topics: Adult; Aged; Biguanides; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Female; Humans; H | 1983 |
[Drug treatment of primary hyperlipoproteinemia (author's transl)].
Topics: Anion Exchange Resins; Biguanides; Cholestyramine Resin; Clofibrate; Colestipol; DEAE-Dextran; Dextr | 1978 |
[Atherosclerosis. Its implications, prevention and dietetic and pharmacological treatment].
Topics: Anticholesteremic Agents; Arteriosclerosis; Biguanides; Cholesterol; Cholestyramine Resin; Clofibrat | 1978 |
[Indications and results of an additional differentiated pharmacotherapy of obesity].
Topics: Adolescent; Adult; Aged; Biguanides; Diabetes Mellitus; Diet, Reducing; Female; Furosemide; Humans; | 1978 |
[NN-dimethylbiguanide attenuates the lipid disorders of rats on an atherogenic diet].
Topics: Animals; Biguanides; Cholesterol; Cholesterol, Dietary; Depression, Chemical; Diet, Atherogenic; Die | 1975 |
[Type distribution of hyperlipoproteinemias in 645 diabetics].
Topics: Biguanides; Cholesterol; Diabetes Complications; Diabetes Mellitus; Female; Humans; Hyperlipidemias; | 1977 |
[Reduction of serum triglycerides with a combined application of butylbiguanide and clofibrate in animal experiments].
Topics: Animals; Biguanides; Buformin; Clofibrate; Depression, Chemical; Drug Interactions; Fructose; Hyperl | 1975 |
[Effect of biguanide derivatives on the indicators of lipid metabolism and the functional state of blood mononuclear cells in patients with insulin-dependent diabetes mellitus].
Topics: Adolescent; Adult; Aged; Arteriosclerosis; Biguanides; Diabetes Mellitus, Type 1; Dose-Response Rela | 1991 |
[Possibilities and limits of primary prevention in diabetes mellitus].
Topics: Biguanides; Body Weight; Diabetes Mellitus; Diabetic Angiopathies; Dietary Carbohydrates; Female; Hu | 1974 |
[Biguanide therapy of primary hyperlipoproteinemias type IIb, 3 and IV as monotherapy and combined with clofibrate].
Topics: Adult; Aged; Biguanides; Clofibrate; Drug Combinations; Humans; Hyperlipidemias; Middle Aged; Phenfo | 1973 |
[Preventive effects of NN'-dimethylbiguanide on the development of cholesterol-induced arteriosclerosis in rabbits].
Topics: Animals; Aorta; Arteriosclerosis; Biguanides; Cholesterol; Hyperlipidemias; Male; Rabbits | 1969 |
The uptake of orally administered trioleate- 14 C in normal and diabetic rats with and without butylbiguanide application.
Topics: Adipose Tissue; Administration, Oral; Animals; Biguanides; Carbon Isotopes; Diabetes Mellitus, Exper | 1971 |
[Antilipidemic agents].
Topics: Adult; Alcohols; Anticholesteremic Agents; Biguanides; Blood Protein Disorders; Body Weight; Cholest | 1971 |
The effect of butylbiguanide on the fat-induced hyperlipemia in normal and alloxan diabetic rats.
Topics: Animals; Biguanides; Diabetes Mellitus, Experimental; Fatty Acids, Nonesterified; Glycerides; Glycer | 1970 |